ArticleCureus2026
Zoster-Like Dermatomal Eruption Following Recombinant Zoster Vaccine: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The reactivation of the varicella zoster virus (VZV) is the cause of herpes zoster (HZ), usually referred to as shingles. Once an individual has been previously infected with chickenpox, the virus stays dormant in their nervous system and may reactivate later in life, leading to HZ. HZ poses a significant burden on the healthcare system due to its high prevalence. Older adults and individuals with compromised immune function are at higher risk of viral reactivation. Vaccination against HZ is a highly effective strategy in preventing viral recurrence and its associated complications. However, recognizing rare post-vaccination zoster-like cutaneous eruptions is essential. In this report, we present a rare instance of a clinically suspected HZ-like eruption in an 85-year-old man who developed an erythematous maculopapular rash with scattered vesicular lesions on his right neck and shoulder one day after receiving a standard dosage vaccine. The patient was treated with valacyclovir for seven days. The immediate recognition of healthcare professionals is the aim of this report to promote early diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.